Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Patrick DeMartino"'
Publikováno v:
JAMA Pediatr
Hundreds of gene therapies are undergoing clinical testing and are likely to be priced more than $1 million per course of treatment. The association that high prices will have with insurance coverage of gene therapy remains unclear. Gene therapy for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25481a1670128b2034a9d8afa810a556
https://europepmc.org/articles/PMC8185597/
https://europepmc.org/articles/PMC8185597/
Publikováno v:
JAMA Pediatr
Importance Hundreds of gene therapies are undergoing clinical testing and are likely to be priced more than $1 million per course of treatment. The association that high prices will have with insurance coverage of gene therapy remains unclear. Gene t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2d246bc139f5b22bf62c001ad046ca
https://europepmc.org/articles/PMC7985816/
https://europepmc.org/articles/PMC7985816/
Autor:
Kimberly M Lerner, Rebecca Hulme, Evan Shereck, Richard T Maziarz, Eneida R. Nemecek, Bill H. Chang, Patrick DeMartino
Publikováno v:
Transplantation and Cellular Therapy. 28:S143
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cdbcef10cb9ed3395a16c67195151eb
https://doi.org/10.1016/s2666-6367(22)00333-5
https://doi.org/10.1016/s2666-6367(22)00333-5
Autor:
Michelle Skinner, Eneida R. Nemecek, Lauren Cheema, Allison Franco, Bill H. Chang, Patrick DeMartino, Evan Shereck, Gail Armstrong
Publikováno v:
Transplantation and Cellular Therapy. 28:S96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b1b19ac1fa6e75d1251a5cc2d3e3ae6
https://doi.org/10.1016/s2666-6367(22)00277-9
https://doi.org/10.1016/s2666-6367(22)00277-9
Publikováno v:
JAMA Intern Med
Importance The growth of cancer drug spending in the US has outpaced spending in nearly all other sectors, and an increasing proportion of the drug development pipeline is devoted to oncology. In 2018, there was a record number of drugs entering the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1989aca4a6a190d866afdf7480ae1a97
https://europepmc.org/articles/PMC7653539/
https://europepmc.org/articles/PMC7653539/
Publikováno v:
Blood. 132:4700-4700
Introduction: Qualitative research identifies delayed analgesia and under-dosing as common reasons for patient/caregiver dissatisfaction with the treatment of acute vaso-occlusive pain in sickle cell disease (SCD). Experts have identified quality mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::525956cad3e571c8b3455a4551760891
https://doi.org/10.1182/blood-2018-99-117703
https://doi.org/10.1182/blood-2018-99-117703